Advertisement
News
Subscribe to MDT Magazine News

Slimming Beauty Bitter Orange Slimming Capsules: Undeclared Drug Ingredient

October 8, 2010 10:33 am | by U.S. Food & Drug Administration | Comments

Product marketed as a dietary supplement contains sibutramine, which can lead to elevated blood pressure, stroke, or heart attack.

LHC plans earnings report on Nov. 1

October 8, 2010 9:45 am | by The Associated Press | Comments

LHC Group, the Lafayette-based provider of home health and hospice services, said Friday that it will report its earnings for the quarter and nine months ended Sept. 30 on Nov. 1.The company said the report will be released after the close of U.S. financial markets.

Z-Medica signs deal to sell blood clot product in Belgium

October 8, 2010 9:32 am | by Mass High Tech: The Journal of New England Technology | Comments

Z-Medica Corp., a Wallingford, Conn.-based medical products maker, has signed a deal that gives Belgian medical device distribution firm Romed NV exclusive sales and distribution rights of its QuikClot hemostatic products in Belgium.

Advertisement

Virginian-Pilot Story Misleads Readers on USDA Inspection Report for PLRS

October 8, 2010 9:32 am | by Bio-Medicine.Org | Comments

CORAPEAKE, N.C., Oct. 8 /- Contrary to a report in today's Virginian-Pilot , a comprehensive inspection by the U.S. Department of Agriculture (USDA) of NC-based Professional Laboratory and Research Services (PLRS) has found no evidence of animal neglect or abuse. The USDA finding follows...

TOPICS:

Abbott Laboratories Agrees to Withdraw Its Obesity Drug Meridia

October 8, 2010 9:32 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., Oct. 8 /PRNewswire-USNewswire/ -- Abbott Laboratories has agreed to voluntarily withdraw its obesity drug Meridia (sibutramine) from the U.S. market because of clinical trial data indicating an increased risk of heart attack and stroke, the U.S. Food and Drug...

TOPICS:

Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS)

October 8, 2010 9:32 am | by Bio-Medicine.Org | Comments

CLEVELAND, Oct. 8 /- Synapse Biomedical Inc . announces today that they have received the U.S. Food and Drug Administration (FDA) designation of the NeuRx Diaphragm Pacing System (DPS)™ as a Humanitarian Use Device (HUD) for amyotrophic lateral sclerosis ( ALS ) patients with a...

TOPICS:

Pioneer® Surgical Technology, Inc. Announces Agreement to Acquire Exclusive Access to the Cequence™ Cervical Plate System From SpineSmith, LP

October 8, 2010 9:31 am | by Bio-Medicine.Org | Comments

MARQUETTE, Mich., Oct. 8 /- Pioneer Surgical Technology, Inc. and SpineSmith, LP are pleased to announce a deal in which Pioneer Surgical will acquire exclusive rights to manufacture and distribute the Cequence™ anterior cervical plate.  As part of the agreement, Pioneer...

TOPICS:

Life cycle of adult hippocampal newborn neuron uncovered

October 8, 2010 8:32 am | by Baylor College of Medicine | Comments

Unlocking the mystery of neurological disorders starts with understanding how neurons are generated and maintained. Recently, researchers at the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital and Baylor College of Medicine discovered that the life cycle of...

TOPICS:
Advertisement

Empowerment fair offers opportunities for women with disabilities

October 8, 2010 8:32 am | by Baylor College of Medicine | Comments

Baylor College of Medicine's Center for Research on Women with Disabilities and the Houston Center for Independent Living will host the first annual Women with Disabilities Empowerment Fair on Saturday, Oct. 30, at 2 p.m. at the Metropolitan Multi-Service Center, 1475 West Gray Street....

TOPICS:

Varian Medical Systems Schedules Fourth Quarter FY2010 News Release and Conference Call

October 8, 2010 6:33 am | by Bio-Medicine.Org | Comments

PALO ALTO, Calif., Oct. 8 /- Varian Medical Systems (NYSE: VAR ) announced today that it will report results for fourth quarter of fiscal year 2010 following the close of regular trading on Thursday, October 28, 2010.  The news release will be followed by a teleconference available...

TOPICS:

3G Wireless Technology Empowers Patients to Take Control of Their Health Through the Dulce Wireless Tijuana Project

October 8, 2010 6:33 am | by Bio-Medicine.Org | Comments

TIJUANA, Mexico, Oct. 8 /- Qualcomm Incorporated (Nasdaq: QCOM ), through its Wireless Reach™ initiative, today announced the launch of the Dulce Wireless Tijuana project.  The project will empower underserved communities to improve diabetes care and prevention through the use...

TOPICS:

Cantel Medical Corp. to Hold Conference Call to Discuss Fourth Quarter and Fiscal 2010 Results

October 8, 2010 6:32 am | by Bio-Medicine.Org | Comments

LITTLE FALLS, N.J., Oct. 8 /- Cantel Medical Corp. (NYSE: CMN ) will release the results for its fourth quarter and fiscal year ended July 31, 2010 on Wednesday, October 13 before the market opens, and hold a conference call to discuss the results at 11:00 AM ET.  Participating in...

TOPICS:

Voices of UC Survey Shows Need for Patients with Ulcerative Colitis to Speak Up about Debilitating Digestive Disease

October 8, 2010 6:32 am | by Bio-Medicine.Org | Comments

HORSHAM, Pa., Oct. 8 /- People living with ulcerative colitis (UC) say greater understanding is needed about the life-altering nature of this chronic inflammatory bowel disease that affects approximately 500,000 Americans.  Data released today from Voices of UC ( voicesofuc.com ), an...

TOPICS:

ACD Wins $3 Million Grant From National Cancer Institute to Develop Its CTCscope™ System for Detection and Molecular Analysis of Circulating Tumor Cells

October 8, 2010 6:31 am | by Bio-Medicine.Org | Comments

HAYWARD, Calif., Oct. 8 /- Advanced Cell Diagnostics, Inc. (ACD) was awarded a three-year, $3 million grant from National Cancer Institute (NCI) under its SBIR Phase II Bridge Award. This grant will support ACD's continuing effort to develop its proprietary CTCscope™ system capable...

TOPICS:

Cytori Therapeutics to offer $18 million in stock

October 8, 2010 5:45 am | by The Associated Press | Comments

Cytori Therapeutics Inc. said Friday it is publicly offering $18 million worth of common stock at discount, sending shares lower in premarket trading.The company is offering 4 million shares at $4.50 apiece, marking a 15.7 percent discount to its closing price of $5.34 on Thursday.Shares fell...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading